With the support of semaglutide, patients have seen an increase in weight loss and fewer fluctuations in blood sugar levels
Some people reach a plateau that requires dietary adjustments, exercise modifications, or discussions with their provider about dose optimization
In non-clinical research settings, glutathione is commonly examined for its involvement in pathways associated with oxidative stress regulation, detoxification processes, and intracellular signaling mechanisms
Finally, achieving lower HbA1c levels with molecules that do not induce hypoglycemia may be associated with a reduced need for intensification and a lower risk of therapeutic inertia
17 Moreover, other trials as the SUSTAIN-6 trial showed that semaglutide, another GLP-1RA also reduced the risk of MACE by 26% and non-fatal stroke by 39% in patients with T2DM